UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007887
Receipt number R000009289
Scientific Title An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy
Date of disclosure of the study information 2012/05/08
Last modified on 2015/06/07 01:12:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy

Acronym

Safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy(ALCT002)

Scientific Title

An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy

Scientific Title:Acronym

Safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy(ALCT002)

Region

Japan


Condition

Condition

Lung cancer patients planned to receive two or more cycles of cisplatin chemotherapy

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of hydration using oral rehydration solution in comparison with the hydration using intravenous solution during cisplatin chemotherapy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

serum creatinine

Key secondary outcomes

serum cystatinC
serum beta2-microglobulin
serum BUN
urine volume
urine sodium
urine NAG
urine beta2-microglobulin
creatinine clearance


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

hydration using intravenous solution
(chemotherapy days 2 and 3)

Interventions/Control_2

Hydration using oral rehydration solution
(chemotherapy days 2 and 3)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients with histologically or cytrologically confirmed diagnosis of lung cancer
2. Patients planned to receive two or more cycles of cisplatin chemotherapy
3. Patients aged between 20 and 74 years
4. Patients with ECOG Performance status of 0 to 2
5. Patients expected to survive longer than at least three months
6. Patients who can be treated after hospitalization
7. Patients who provide written informed consent
8. Patients who have never been treated with cisplatin previously

Key exclusion criteria

1. Patients with the serum creatinine level exceeding the upper limit of the hospital or with the estimated Ccr of 60mL/min or lower
2. Patients with intractable ascites or pleural effusion except those who have been treated by pleurodesis.
3. Patients with psychiatric disease or psychological symptom
4. Female patients of childbearing potential, pregnancy, or lactation
5. Patients with poorly controlled diabetes
6. Patients who meet the criteria specified in "contraindication" or "careful administration" in the package inserts of the intravenous solutions used in the study
7. Patients with difficulty eating or with grade 2 or higher anorexia (CTCAE 4.0)
8. Patients otherwise deemed unsuitable for inclusion in the study for any other reason based on the assessment by the investigator

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takuma Yokoyama

Organization

Kyorin Univercity Hospital

Division name

Department of Respiratory Medicine

Zip code


Address

6-20-2 shinkawa,Mitaka city,Tokyo

TEL

0422-47-5511

Email

taku@ks.kyorin-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takuma Yokoyama

Organization

Kyorin Univercity Hospital

Division name

Department of Respiratory Medicine

Zip code


Address

6-20-2 shinkawa,Mitaka city,Tokyo

TEL

0422-47-5511

Homepage URL


Email

taku@ks.kyorin-u.ac.jp


Sponsor or person

Institute

Department of Respiratory Medicine
Kyorin Univercity Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 02 Month 17 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2014 Year 04 Month 30 Day

Date of closure to data entry

2014 Year 04 Month 30 Day

Date trial data considered complete

2014 Year 04 Month 30 Day

Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 05 Month 03 Day

Last modified on

2015 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009289


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name